The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Recombinant human antithrombin (Brand name: Atryn®)
- Manufactured by
GTC Biotherapeutics, Inc.
FDA-approved indication: Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.
National Library of Medicine Drug Information Portal